Moxifloxacin Teva (Moxifloxacin Hydrochloride)

Moxifloxacin, the active ingredient in Moxifloxacin Teva, is a fluoroquinolone antibiotic presented as an injection for intravenous use. It treats bacterial infections in adult patients.

GNH USA supplies Moxifloxacin Teva as a licensed, GDP-compliant international pharmaceutical supplier serving hospitals worldwide.

Moxifloxacin Teva is a fluoroquinolone antibiotic used to treat serious bacterial infections.

- Community‑acquired bacterial pneumonia: achieves clinical cure and bacterial eradication. - Acute bacterial sinusitis: reduces symptoms and eliminates pathogenic bacteria. - Acute exacerbation of chronic bronchitis: improves respiratory function and clears infection. - Skin and soft‑tissue infections: promotes healing by eradicating susceptible organisms. - Intra‑abdominal infections: provides broad‑spectrum coverage for mixed bacterial flora.

Moxifloxacin may cause a range of adverse reactions.

Common Side Effects: - Nausea - Diarrhea - Headache - Dizziness - Injection site pain - Elevated liver enzymes

Serious or Rare Side Effects: - Tendon rupture or tendonitis - QT interval prolongation leading to arrhythmia - Severe allergic reactions (anaphylaxis, Stevens‑Johnson syndrome) - Clostridioides difficile‑associated colitis - Hepatic failure - Severe skin reactions such as toxic epidermal necrolysis

Use of Moxifloxacin requires careful clinical assessment.

- Renal impairment: adjust therapy based on renal function. - History of tendon disorders: avoid use due to risk of tendon rupture. - Cardiac arrhythmias: monitor QT interval during treatment. - Concurrent use with other QT‑prolonging drugs: avoid combination. - Pregnancy and lactation: use only if benefits outweigh risks. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Moxifloxacin can interact with several medications.

Major Interactions (Avoid): - Co‑administration with other fluoroquinolones: increased toxicity. - Concurrent use with QT‑prolonging drugs (e.g., quinidine, macrolides): risk of cardiac arrhythmia. - Non‑steroidal anti‑inflammatory drugs (NSAIDs): may reduce antibacterial activity. - Antacids containing aluminum or magnesium: may impair absorption. - Warfarin: may enhance anticoagulant effect.

Moderate Interactions (Monitor Closely): - Corticosteroids: increased risk of tendon rupture. - Theophylline: may increase plasma levels. - Cyclosporine: potential for increased toxicity.